iRhythm Technologies

iRhythm Technologies' mission is to provide diagnostic clarity through data, revolutionizing the detection and management of cardiac arrhythmias. The company has achieved market leadership with its end-to-end Zio® service, which boasts exceptional patient compliance, a vast proprietary database of over 2 billion hours of ECG data, and AI-generated reports with 99% physician agreement. Its strategy centers on leveraging its integrated 'Clarity by Design' platform—encompassing device, AI, and clinical services—to drive adoption, improve clinical outcomes, and expand into new cardiac care pathways.

The 'Clarity by Design' platform integrates long-term wearable ECG monitors (Zio®), a proprietary deep-learned AI algorithm for arrhythmia detection, and expert clinical review to deliver a comprehensive, end-to-end cardiac monitoring service.

iRhythm competes with traditional Holter monitor providers (e.g., Philips), consumer ECG devices (e.g., Apple Watch, KardiaMobile), and insertable cardiac monitors (e.g., Medtronic). Its key advantages are superior patient compliance, an integrated AI-powered service model, and a vast proprietary data moat.